ArticlePloS one2020

Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line.

Yoshinori Tsukumo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.